Abstract
Background Although the number of intensive care unit (ICU) beds is crucial during the COVID-19 epidemic caring for the most critically ill infected patients, there is no recognized early indicator to anticipate ICU bed requirements.
Methods In the Ile-de-France region, from February 20 to May 5, 2020, emergency medical service (EMS) calls and the response provided (ambulances) together the percentage of positive reverse transcriptase polymerase chain reaction (RT-PCR) tests, general practitioner (GP) and emergency department (ED) visits, and hospital admissions of COVID-19 patients were recorded daily and compared to the number of COVID-19 ICU patients. Correlation curve analysis was performed to determine the best correlation coefficient (R), depending on the number of days the indicator has been shifted. A delay ≥7 days was considered as an early alert, and a delay ≥14 days a very early alert.
Findings EMS calls, percentage of positive RT-PCR tests, ambulances used, ED and GP visits of COVID-19 patients were strongly associated with COVID-19 ICU patients with an anticipation delay of 23, 15, 14, 13, and 12 days respectively. Hospitalization did not anticipate ICU bed requirement.
Interpretation The daily number of COVID19-related telephone calls received by the EMS and corresponding dispatch ambulances, and the proportion of positive RT-PCR tests were the earliest indicators of the number of COVID19 patients requiring ICU care during the epidemic crisis in the Ile-de-France region, rapidly followed by ED and GP visits. This information may help health authorities to anticipate a future epidemic, including a second wave of COVID19 or decide additional social measures.
Funding Only institutional funding was provided.
Evidence before the study We searched PubMed and preprint archives for articles published up to May 17, 2020, that contained information about the anticipation of intensive care unit (ICU) bed requirement during the COVID-19 outbreak using the terms “coronavirus”, “2009-nCOV”, “COVID-19”, SARS-CoV2”, “prediction” “resource” and “intensive care”. We also reviewed relevant references in retrieved articles and the publicly available publication list of the COVID-19 living systematic review.22 This list contains studies on covid-19 published on PubMed and Embase through Ovid, bioRxiv, and medRxiv, and is continuously updated. Although many studies estimated the number of patients who would have severe COVID-19 requiring ICU, very few contained assessment for early signals (from internet or social media), and we retrieved no study whose data came from suspected or infected patients.
Added values of this study During the COVID-19 epidemic, emergency medical system (EMS) calls, percentage of positive reverse transcriptase polymerase chain reaction (RT-PCR) tests, ambulance dispatch, emergency department (ED) and general practitioner (GP) visits of COVID-19 patients were strongly associated with COVID-19 ICU patients with an anticipation delay of 23, 15, 14, 13, and 12 days respectively. Hospitalization did not anticipated COVID-19 ICU bed requirement.
Implication of all available evidence EMS calls and ambulance dispatch, percent of positive RT-PCR, and ED and GP visits could be valuable tools as daily alert signals to set up plan to face the burden of ICU bed requirement during the initial wave of the COVID-19 epidemic, and may possibly also help anticipating a second wave. These results are important since mortality has been reported being correlated to health care resources.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Study performed on anomymised data publicly available
Funding Statement
Support was provided only by institutional sources
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Sorbonne Universite ethical committee (CER Number 2020-55, Paris, France). Patient consent was not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* List of investigators by alphabetical order:
Prof. Frédéric Adnet (SAMU 93, Assistance Publique-Hôpitaux de Paris [APHP], Université Paris 13, Institut National de la Santé et de la Recherche Médicale [INSERM], Bobigny); Marin Boyet (Institut National de la Recherche en Informatique et en Automatique [INRIA], Ecole polytechnique, and Centre National de la Recherche Scientifique [CNRS], Paris); Dr. Jean-Jacques Avrane (SOS médecins, Paris); Prof. Frédéric Batteux (Université de Paris and APHP, Paris); Prof. Pierre-Yves Boëlle (Sorbonne Université, INSERM, and APHP); Dr. Jérémie Boutet (SAMU 92, APHP, Garches) Prof. Vincent Calvez (Sorbonne Université, INSERM, and APHP, Paris); Prof Pierre Carli (SAMU zonal, APHP and Université de Paris, Paris); Dr. Pascal Chansard (SOS Médecins, Paris); Dr. Charlotte Chollet (SAMU 94, APHP, Créteil); François Crémieux (deputy CEO, APHP, Paris); Pr. Diane Descamps (Université de Paris, INSERM, and APHP, Paris); Prof. Stéphane Gaubert (INRIA, Ecole polytechnique, and CNRS, Paris); Dr. Laurent Goix (SAMU 93, APHP, Bobigny); Pr. Pierre Hausfater (Sorbonne Université and APHP, Paris); Martin Hirsch (CEO APHP, Paris); Dr. Eric Lecarpentier (SAMU 94, APHP, Créteil); Dr. Thomas Loeb (SAMU 92, APHP, Garches); Dr. Jean-Sébastien Marx (SAMU 75, APHP, Paris); Prof. Catherine Paugam (Université de Paris, INSERM, and APHP, Clichy); Prof. Renaud Piarroux (Sorbonne Université, INSERM, and APHP, Paris); Prof. Bruno Riou (Sorbonne Université, INSERM, and APHP, Paris); Prof. Remi Salomon (Université de Paris and APHP, Paris); Dr. Serge Smadja (SOS Médecins, Paris); Dr. Caroline Telion (SAMU 75, APHP, Paris); Prof. Antoine Vieillard- Baron (Université Versailles St Quentin and Yvelynes and APHP, Boulogne).
Data Availability
Some data were extracted from a publicly available source others from Assistance Publique-Hopitaux de Paris (Paris, France) warehouse (Entrepot des Donnees de Sante, EDS) are available on request.
